I hate to burst your bubble, but Ampligen rarely achieves a 100% reversal of symptoms. Even people who do very well on it usually still have some degree of PEM and have to be careful not to overdo it.
I've heard that Dr. Peterson has said that the number of people that get at least some improvement on the drug is closer to 70%. That was posted somewhere here on PR--when I have more time I'll look for it. It sure would be nice to get a definitive figure, wouldn't it?
I've never heard that Hemispherx making the FDA angry for their lousy business practices is what caused them to reject their new drug application. The FDA has specific reasons in their rejection and they were all protocol-related. If I remember correctly from the new drug application, it was that they hadn't shown enough efficacy. In order to get reconsidered, they have to do that, test the drug at several different doses to find out which one is the best one, and clean up their manufacturing quality control.
Of course, I'm not denying that the FDA can be influenced by politics!
I don't believe Hemispherx is being more restrictive about who gets the drug. Basically, they will take anyone who can pay and who doesn't have certain co-morbid conditions and can get off the drugs that are counter-indicated by the study.
If you have any more info to back up some of the claims you've made, I'd really like to see it. There is so little in the way of hard facts known about this drug (by anyone other than Hemispherx, who isn't talking) that it must be really difficult for someone to decide whether to put out the large amount of money needed to get the drug.